eHSP90α interacts with lysyl oxidase-like 2 (LOXL2) and allows the latter to assume its functional conformation favoring the migration of breast cancer cells [115] and with tissue plasminogen activator (tPA), favoring the conversion of plasminogen in plasmin, a process that favors cancer invasion [116]. The gene discussed is PLG; the disease is cancer.